Immunologic recovery after 2-years on HAART in vertically HIV-infected children

Medicina Clinica

Volumn 118, Issue 16, 2002, Pages 601-604

  Resino, Salvador ^a   Bellón, José M ^a   Gurbindo, Dolores ^b   Tomás Ramos, José ^c   Navarro, Marisa ^b   León, Juan Antonio ^d   Clemente, Julián ^c   Angeles Munoz Fernandez M ^a  

^a Servicio de Inmunología   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Children; HAART; HIV 1; Recovery; T cell subsets

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; REMISSION; RETROSPECTIVE STUDY; TIME; AGE; CLINICAL ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MEMORY CELL; T LYMPHOCYTE SUBPOPULATION; VERTICAL TRANSMISSION; VIRUS REPLICATION;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; HIV INFECTIONS; HUMANS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS;

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; PADGEM PROTEIN;

EID: 0037018719     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(02)72467-6     Document Type: Article

References (31)

1. The efficacy of antiretroviral treatment in patients with human immunodeficiency virus infection. A study of 807 patients
2. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
3. Effect of changing antiretroviral therapy on human immunodeficiency virus viral load: Experience with fifty-four perinatally infected children
4. Viral load and CD4+ lymphocyte count in the era of highly active antiretroviral therapy
5. Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: A multicenter study in the Netherlands. On behalf of for Children with HIV-1 infections
6. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume
7. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells
8. Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans
9. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selection on T cells during the virgin to memory cell transition
10. Lymphocyte homing and homeostasis
11. Recovery of the immune system with antiretroviral therapy: The end of opportunism?
12. CD8+, CD38+ lymphocyte percent: A useful immunological marker for monitoring HIV-1-infected patients
13. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years
14. Increased expression of activation markers on CD8 lymphocytes in children with human immunodeficiency virus-1 infection
15. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune combinations of HLA-DR and CD38 expression
16. Role of CD38 in HIV-1 infection: An epiphenomenon of T-cell activation or an active player in virus/host interactions?
17. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection
18. Revised classification system for HIV-1 infection in children less than 13 years of age
19. Guidelines for use of antiretroviral agents in pediatric HIV infection
20. Asociación de subpoblaciones linfocitarias T con marcadores pronósticos de la infección pediátrica por el VIH
21. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV-1 infection in children treated with highly active antiretroviral therapy
22. Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents
23. Effect of protease therapy on cytokine secretion by peripheral blood mononuclear cells (PBMC) from HIV-infected subjects
24. Differential responses of T cell subsets: Possible role in the immunopathogenesis of AIDS
25. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse
26. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection
27. Relationship between CD4+ T-lymphocyte subsets and the laboratory markers used to monitor the HIV-1 infection in children with potent antirretroviral therapy
28. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro
29. Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression
30. Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study
31. Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection